JNJ

237.61

+1.2%↑

UNH

266.5

-4.07%↓

TMO

546.08

-3.61%↓

ABT

109.17

+0.16%↑

ISRG

476.92

-0.47%↓

JNJ

237.61

+1.2%↑

UNH

266.5

-4.07%↓

TMO

546.08

-3.61%↓

ABT

109.17

+0.16%↑

ISRG

476.92

-0.47%↓

JNJ

237.61

+1.2%↑

UNH

266.5

-4.07%↓

TMO

546.08

-3.61%↓

ABT

109.17

+0.16%↑

ISRG

476.92

-0.47%↓

JNJ

237.61

+1.2%↑

UNH

266.5

-4.07%↓

TMO

546.08

-3.61%↓

ABT

109.17

+0.16%↑

ISRG

476.92

-0.47%↓

JNJ

237.61

+1.2%↑

UNH

266.5

-4.07%↓

TMO

546.08

-3.61%↓

ABT

109.17

+0.16%↑

ISRG

476.92

-0.47%↓

Search

Evolent Health Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

2.96 -3.58

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.89

Max

3.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

30M

-21M

Pardavimai

35M

480M

Pelno marža

-4.351

Darbuotojai

4,500

EBITDA

512K

15M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+185.76% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-02-24

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-401M

378M

Ankstesnė atidarymo kaina

6.54

Ankstesnė uždarymo kaina

2.96

Naujienos nuotaikos

By Acuity

43%

57%

124 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Evolent Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-05 00:00; UTC

Karštos akcijos

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

2026-02-04 22:55; UTC

Uždarbis

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

2026-02-04 21:44; UTC

Uždarbis

Arm Holdings 3Q Profit Falls Despite Revenue Growth

2026-02-04 21:39; UTC

Uždarbis

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

2026-02-05 00:00; UTC

Uždarbis

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

2026-02-05 00:00; UTC

Uždarbis

Renesas Electronics FY Loss Y51.76B Vs Net Y219.08B

2026-02-04 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

2026-02-04 23:45; UTC

Uždarbis

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

2026-02-04 23:32; UTC

Rinkos pokalbiai

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

2026-02-04 22:59; UTC

Įsigijimai, susijungimai, perėmimai

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

2026-02-04 22:30; UTC

Uždarbis

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

2026-02-04 22:30; UTC

Uždarbis

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

2026-02-04 22:21; UTC

Uždarbis

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026-02-04 22:17; UTC

Rinkos pokalbiai

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

2026-02-04 22:15; UTC

Rinkos pokalbiai

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

2026-02-04 22:00; UTC

Rinkos pokalbiai

ESG Roundup: Market Talk

2026-02-04 21:53; UTC

Uždarbis

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

2026-02-04 21:51; UTC

Uždarbis

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

2026-02-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-02-04 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-02-04 21:50; UTC

Rinkos pokalbiai
Uždarbis

Auto & Transport Roundup: Market Talk

2026-02-04 21:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-02-04 21:45; UTC

Uždarbis

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

2026-02-04 21:44; UTC

Uždarbis

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

2026-02-04 21:43; UTC

Uždarbis

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

2026-02-04 21:41; UTC

Uždarbis

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

2026-02-04 21:36; UTC

Rinkos pokalbiai

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

2026-02-04 21:30; UTC

Uždarbis

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026-02-04 21:30; UTC

Uždarbis

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

2026-02-04 21:30; UTC

Uždarbis

Beach Energy Interim Dividend 1 Australian Cent/Sjare

Akcijų palyginimas

Kainos pokytis

Evolent Health Inc Prognozė

Kainos tikslas

By TipRanks

185.76% į viršų

12 mėnesių prognozė

Vidutinis 8.83 USD  185.76%

Aukščiausias 15 USD

Žemiausias 5 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Evolent Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

14 ratings

13

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

10.33 / 10.95Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

124 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat